ONB
MRNA icon

Old National Bancorp’s Moderna MRNA Stock Holding History

Old National Bancorp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,415
Closed -$254K – 705
2022
Q4 		$254K Buy
+1,415
New +$231K 0.01% 582
2022
Q3 		– Sell
-2,334
Closed -$333K – 704
2022
Q2 		$333K Buy
+2,334
New +$334K 0.01% 478

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Old National Bancorp's MRNA Position: Q1 2023 in Review

Old National Bancorp sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,415 shares — an estimated $254K sold.

Old National Bancorp first reported a position in MRNA in Q2 2022 and held it in 2 quarters. The position peaked at $333K in Q2 2022. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Old National Bancorp reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Old National Bancorp sold 1,415 Moderna shares in Q1 2023, an estimated $254K.
  • Old National Bancorp first reported a position in Moderna in Q2 2022 and held it in 2 quarters.
  • Old National Bancorp's Moderna position peaked at $333K in Q2 2022.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Old National Bancorp's 13F filing for Q1 2023, filed 19 Apr 2023.